IL135430A0 - Method and compositions for inducing tumor specific cytotoxicity - Google Patents
Method and compositions for inducing tumor specific cytotoxicityInfo
- Publication number
- IL135430A0 IL135430A0 IL13543098A IL13543098A IL135430A0 IL 135430 A0 IL135430 A0 IL 135430A0 IL 13543098 A IL13543098 A IL 13543098A IL 13543098 A IL13543098 A IL 13543098A IL 135430 A0 IL135430 A0 IL 135430A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- tumor specific
- specific cytotoxicity
- inducing tumor
- sequences
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000003013 cytotoxicity Effects 0.000 title 1
- 231100000135 cytotoxicity Toxicity 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 abstract 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 1
- 102000048143 Insulin-Like Growth Factor II Human genes 0.000 abstract 1
- 108090001117 Insulin-Like Growth Factor II Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000002103 transcriptional effect Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94360897A | 1997-10-03 | 1997-10-03 | |
| PCT/IL1998/000486 WO1999018195A2 (en) | 1997-10-03 | 1998-10-04 | Methods and compositions for inducing tumor-specific cytotoxicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL135430A0 true IL135430A0 (en) | 2001-05-20 |
Family
ID=25479934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13543098A IL135430A0 (en) | 1997-10-03 | 1998-10-04 | Method and compositions for inducing tumor specific cytotoxicity |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US6087164A (xx) |
| EP (1) | EP1019499B1 (xx) |
| JP (3) | JP5153031B2 (xx) |
| KR (1) | KR100524262B1 (xx) |
| CN (1) | CN1229496C (xx) |
| AT (1) | ATE407948T1 (xx) |
| AU (1) | AU755774B2 (xx) |
| BR (1) | BR9812717B1 (xx) |
| CA (1) | CA2308124C (xx) |
| CZ (2) | CZ294941B6 (xx) |
| DE (1) | DE69840001D1 (xx) |
| HU (1) | HU228470B1 (xx) |
| IL (1) | IL135430A0 (xx) |
| NO (2) | NO328470B1 (xx) |
| PL (1) | PL339949A1 (xx) |
| RU (1) | RU2214280C2 (xx) |
| WO (1) | WO1999018195A2 (xx) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040006220A1 (en) * | 2002-07-02 | 2004-01-08 | Isis Pharmaceuticals Inc. | Antisense modulation of insulin-like growth factor 2 expression |
| US7041654B2 (en) * | 1997-10-03 | 2006-05-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Methods and compositions for inducing tumor-specific cytotoxicity |
| DE19956568A1 (de) * | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| EP1169480A4 (en) * | 1999-04-14 | 2005-02-02 | Musc Found For Res Dev | TISSUE-SPECIFIC AND PATHOGENIC TOXIC SUBSTANCES AND RIBOZYMES |
| DE19928342A1 (de) * | 1999-06-21 | 2000-12-28 | Deutsches Krebsforsch | Vektoren zur gentherapeutischen Tumorbehandlung |
| US7829693B2 (en) * | 1999-11-24 | 2010-11-09 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of a target gene |
| WO2002046449A2 (en) * | 2000-12-07 | 2002-06-13 | The Penn State Research Foundation | Selection of catalytic nucleic acids targeted to infectious agents |
| US8546143B2 (en) | 2001-01-09 | 2013-10-01 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of a target gene |
| US20040005567A1 (en) * | 2002-07-02 | 2004-01-08 | Isis Pharmaceuticals Inc. | Antisense modulation of cyclin-dependent kinase 4 expression |
| WO2003102186A1 (fr) * | 2002-05-31 | 2003-12-11 | Medinet Co., Ltd. | Adn induisant l'expression specifique des cellules cancereuses et vecteur d'expression specifique des cellules cancereuses |
| US20040180844A1 (en) * | 2003-03-10 | 2004-09-16 | Fesik Stephen W. | Method of killing cancer cells |
| US20040219099A1 (en) * | 2003-05-02 | 2004-11-04 | Jasbir Sandhu | Method for the treatment of tumors |
| US20040220085A1 (en) * | 2003-05-02 | 2004-11-04 | Jasbir Sandhu | Compositions for nucleic acid delivery |
| US7482156B2 (en) * | 2003-10-15 | 2009-01-27 | Cell Genesys, Inc. | Hepatocellular carcinoma specific promoter and uses thereof |
| US7063947B2 (en) * | 2004-04-08 | 2006-06-20 | Promogen, Inc. | System for producing synthetic promoters |
| US7429482B2 (en) * | 2005-01-13 | 2008-09-30 | United States Of America As Represented By The Department Of Veterans Affairs | Screening tools for discovery of novel anabolic agents |
| AU2006267841B2 (en) | 2005-07-07 | 2011-12-15 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Nucleic acid agents for downregulating H19, and methods of using same |
| WO2007034487A1 (en) | 2005-09-22 | 2007-03-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Nucleic acid constructs, pharmaceutical compositions and methods of using same for treating cancer |
| ATE548454T1 (de) * | 2007-01-16 | 2012-03-15 | Yissum Res Dev Co | Nukleinsäurewirkstoffe zur stilllegung von h19 zwecks behandlung rheumatoider arthritis |
| JP2010540534A (ja) | 2007-09-28 | 2010-12-24 | イントレキソン コーポレーション | 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用 |
| EP2203187B1 (en) * | 2007-10-25 | 2012-08-29 | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. | Constructs containing multiple expression cassettes for cancer therapy |
| EP2298866A4 (en) * | 2008-07-02 | 2013-11-20 | Otsuka Pharma Co Ltd | ARTIFICIAL KIDNEY PRECURSOR AND METHOD FOR PRODUCING THE SAME |
| WO2010084488A1 (en) | 2009-01-20 | 2010-07-29 | Ramot At Tel-Aviv University Ltd. | Mir-21 promoter driven targeted cancer therapy |
| EA016223B1 (ru) * | 2009-10-07 | 2012-03-30 | Учреждение Российской Академии Наук Институт Молекулярной Генетики Ран | Способ и генная конструкция для высокоспецифичного ингибирования нежелательного роста клеток |
| CN107735079A (zh) | 2015-05-05 | 2018-02-23 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 核酸‑阳离子聚合物组合物及其制备和使用方法 |
| AU2019261982A1 (en) * | 2018-04-30 | 2020-10-15 | Amicus Therapeutics, Inc. | Gene therapy constructs and methods of use |
| CN110714075B (zh) * | 2018-07-13 | 2024-05-03 | 立森印迹诊断技术（无锡）有限公司 | 一种用于检测肺肿瘤良恶性程度的分级模型及其应用 |
| CN111206093A (zh) * | 2018-11-21 | 2020-05-29 | 立森印迹诊断技术（无锡）有限公司 | 一种用于检测浸润性膀胱癌的标志物及其应用 |
| CN109609505A (zh) * | 2019-01-14 | 2019-04-12 | 中国科学院成都生物研究所 | 一种体内筛选的剪切rna的锤头状核酶 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2699191B1 (fr) * | 1992-12-16 | 1995-02-10 | Univ Paris Curie | Nouveaux vecteurs rétroviraux, lignées cellulaires les contenant, et leur utilisation dans le traitement des tumeurs. |
| US5631236A (en) * | 1993-08-26 | 1997-05-20 | Baylor College Of Medicine | Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk |
| IL108879A (en) * | 1994-03-07 | 2000-08-31 | Yissum Res Dev Co | Diagnostic assay for malignancies using the H19 gene and kit |
| FR2723697B1 (fr) * | 1994-08-17 | 1996-09-20 | Rhone Poulenc Rorer Sa | Methode de traitement de la restenose par la therapie genique |
| FR2725213B1 (fr) * | 1994-10-04 | 1996-11-08 | Rhone Poulenc Rorer Sa | Vecteurs viraux et utilisation en therapie genique |
-
1998
- 1998-10-01 US US09/165,240 patent/US6087164A/en not_active Expired - Lifetime
- 1998-10-04 WO PCT/IL1998/000486 patent/WO1999018195A2/en active IP Right Grant
- 1998-10-04 CN CNB988118335A patent/CN1229496C/zh not_active Expired - Lifetime
- 1998-10-04 KR KR10-2000-7003609A patent/KR100524262B1/ko not_active IP Right Cessation
- 1998-10-04 BR BRPI9812717-9A patent/BR9812717B1/pt not_active IP Right Cessation
- 1998-10-04 DE DE69840001T patent/DE69840001D1/de not_active Expired - Lifetime
- 1998-10-04 PL PL98339949A patent/PL339949A1/xx unknown
- 1998-10-04 HU HU0003745A patent/HU228470B1/hu unknown
- 1998-10-04 EP EP98947759A patent/EP1019499B1/en not_active Expired - Lifetime
- 1998-10-04 IL IL13543098A patent/IL135430A0/xx active IP Right Grant
- 1998-10-04 JP JP2000514993A patent/JP5153031B2/ja not_active Expired - Lifetime
- 1998-10-04 CA CA002308124A patent/CA2308124C/en not_active Expired - Lifetime
- 1998-10-04 CZ CZ2004741A patent/CZ294941B6/cs not_active IP Right Cessation
- 1998-10-04 CZ CZ20001201A patent/CZ294694B6/cs not_active IP Right Cessation
- 1998-10-04 AT AT98947759T patent/ATE407948T1/de not_active IP Right Cessation
- 1998-10-04 AU AU94571/98A patent/AU755774B2/en not_active Expired
- 1998-10-04 RU RU2000111553/14A patent/RU2214280C2/ru active
-
2000
- 2000-03-31 NO NO20001684A patent/NO328470B1/no not_active IP Right Cessation
- 2000-05-10 US US09/568,059 patent/US6306833B1/en not_active Expired - Lifetime
-
2006
- 2006-05-24 JP JP2006144648A patent/JP2006304801A/ja not_active Withdrawn
-
2007
- 2007-10-18 JP JP2007270777A patent/JP2008136480A/ja active Pending
-
2009
- 2009-10-22 NO NO20093194A patent/NO331723B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL135430A0 (en) | Method and compositions for inducing tumor specific cytotoxicity | |
| ZA988124B (en) | Mage-3 peptides presented by HLA class II molecules | |
| ZA935915B (en) | Modified fungal cells and method for producing recombinant products | |
| FI972225A (fi) | Vektorit kudosspesifistä replikaatiota varten | |
| EP1308515A3 (en) | Porcine factor VIII | |
| SG131594G (en) | Expression of human proapolipoprotein A-1 | |
| WO1999064579A3 (en) | Corn oleosin promoter and genes encoding corn desaturases | |
| MX9705039A (es) | Genes y proteinas de muerte celular programada. | |
| PL314239A1 (en) | Recombinated adenovirus vector and method of using it | |
| IL135776A0 (en) | Recombinational cloning using nucleic acids having recombination sites | |
| WO1997022695A3 (fr) | Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer | |
| HK1008347A1 (en) | Dorsal tissue affecting factor and compositions | |
| GR3024379T3 (en) | Peptides with organo-protective activity, the process for preparing them and their use in therapy | |
| IL126152A0 (en) | Recombinant adenoviral vectors for human tumor gene therapy | |
| SI1212428T1 (en) | Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression | |
| NZ303588A (en) | Mpl ligand analogs having one or more changed glycosylation sites uses for these ligand analogs and dna sequences encoding them | |
| EP0631474A4 (en) | Cyclic anti-tumor promoter compounds, compositions and methods for production and use. | |
| WO2001081404A3 (en) | INDUCIBLE PLASMID VECTOR ENCODING TGF-β AND USES THEREOF | |
| ZA981948B (en) | Photodynamic Therapy Generated Oxidative Stress for Temporal and Selective Expression of Heterologous Genes. | |
| WO2000078939A3 (de) | Vektoren zur gentherapeutischen tumorbehandlung | |
| GB9312070D0 (en) | Untranslated exon-1 sequences of eukaryotic genes as promoters | |
| WO1994011522A3 (de) | Vektor zur expression von therapeutisch relevanten genen | |
| PL315670A1 (en) | Expression of heterological proteins in attenuated bacteria with use of htra promoters | |
| WO2001087934A3 (en) | Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides | |
| MX9706483A (es) | Metodos y composiciones para administrar vectores de terapia de genes. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed |